Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

SeLux Diagnostics

Explore full profile

SeLux Diagnostics is developing universal synthetic amplifier technology equipment for antibiotic susceptibility testing and diagnostics

Boston, United StatesFounded 2014Biotech & Life Sciences
Valuation $250–500M Last recorded · 2024
Headcount <100 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for SeLux Diagnostics and the history behind them.

About SeLux Diagnostics

Selux Diagnostics is a healthcare startup that operates in the field of antibiotic susceptibility testing (AST). The company's mission is to combat antimicrobial resistance (AMR), a global health crisis that is seeing bacteria evolve faster than science, leading to resistance to lifesaving antibiotics. Selux aims to preserve the effectiveness of antibiotics for future generations by providing faster diagnostic results, comprehensive susceptibility testing, and updated breakpoints.

The company's primary clients are hospitals and healthcare providers who need accurate and rapid AST to prescribe the correct antibiotics. Selux's technology allows testing against all commercially relevant antibiotics at once, which is a significant innovation in a field that hasn't seen substantial progress in over two decades.

Selux's business model revolves around providing its AST technology to healthcare providers. The company makes money by selling its testing services, which are crucial in the fight against antibiotic resistance. By providing faster and more accurate results, Selux helps reduce the unnecessary or incorrect prescription of antibiotics, which is a significant issue in hospitals.

In summary, Selux Diagnostics is a pioneering healthcare startup that is addressing the global health crisis of antibiotic resistance through its innovative AST technology. The company serves healthcare providers by offering rapid and comprehensive antibiotic susceptibility testing, helping to ensure the correct prescription of antibiotics and ultimately saving lives.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2014
Headquarters
Boston, United States
Employees
14
Open positions
None listed
Dealroom signal
59.8/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Testing, Biotechnology, Health Diagnostics, Biotech and Pharma, Hard Tech, medical testing, DT and LS, science-based
Client focus
b2b

Funding history

10 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCOther financing Apr 2024 $48M $192M Schooner Capital · Northpond Ventures · RA Capital Management ↗
DEBTDebt Feb 2024 $40M — Undisclosed ↗
Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

SeLux Diagnostics website traffic

Latest recorded traffic for SeLux Diagnostics is 2.3K monthly website visits, down 28.1% over the last three months. SeLux Diagnostics's team declined 26.3% over the past year.

Latest monthly visits2.3K 3-month web change-28.1% 1-year team growth-26.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • National Institutes of Health
  • US Biomedical Advanced Research and Development Authority

Series A3 investors entered at this stage

Series B and later2 investors entered at this stage

  • Northpond Ventures
  • Oxford Finance
Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about SeLux Diagnostics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See SeLux Diagnostics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.